Induction of immunogenic cell death through cellular delocalization of calreticulin in acute myeloid leukemia (AML)

被引:0
|
作者
Mans, S. [1 ]
Klebig, C. [1 ]
Shan, D. [1 ]
Mueller, B. U. [2 ]
Pabst, T. [3 ]
机构
[1] Univ Bern, Dept Klin Forsch, Bern, Switzerland
[2] Univ Spital, Kiln Allgemeine Innere Med, Bern, Switzerland
[3] Univ Spital, Dept Med Onkol, Bern, Switzerland
来源
ONKOLOGIE | 2010年 / 33卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:230 / 231
页数:2
相关论文
共 50 条
  • [1] Immunogenic cell death (ICD) genes predict immunotherapy response and therapeutic targets in acute myeloid leukemia (AML)
    Wen, Shuang
    Lv, Xuefeng
    Ma, Xiaohan
    Deng, Shu
    Xie, Jinming
    Yuan, Enwu
    FRONTIERS IN GENETICS, 2024, 15
  • [2] Mechanisms of Tolerance Induction through T Regulatory Cells during Chemotherapy-Mediated Immunogenic Cell Death in Acute Myeloid Leukemia
    Ocadlikova, Darina
    Casella, Serenella
    Pintao, Ines
    Adinolfi, Elena
    Sangaletti, Sabina
    De Marchi, Elena
    Pegoraro, Anna
    Orioli, Elisa
    Colombo, Mario Paolo
    Di Virgilio, Francesco
    Cavo, Michele
    Curti, Antonio
    BLOOD, 2019, 134
  • [3] Construction of a prognostic model of acute myeloid leukemia associated with immunogenic cell death
    Sheng, Xinge
    Lu, Jingyuan
    Wang, Jiaqi
    Fan, Kaiwen
    Huang, Meijiao
    Lu, Quanyi
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (07) : 543 - 551
  • [4] Dietary γ-mangostin triggers immunogenic cell death and activates cGAS signaling in acute myeloid leukemia
    Long, Zi-Jie
    Wang, Jun-Dan
    Qiu, Sheng-Xiang
    Zhang, Yi
    Wu, Si-Jin
    Lei, Xin-Xing
    Huang, Ze-Wei
    Chen, Jia-Jie
    Yang, Yong-Liang
    Zhang, Xiang-Zhong
    Liu, Quentin
    PHARMACOLOGICAL RESEARCH, 2023, 197
  • [5] Quantitation of calreticulin exposure associated with immunogenic cell death
    Liu, Peng
    Zhao, Liwei
    Kepp, Oliver
    Kroemer, Guido
    TUMOR IMMUNOLOGY AND IMMUNOTHERAPY - CELLULAR METHODS, PT B, 2020, 632 : 1 - 13
  • [6] Induction of acute myeloid leukemia (AML) with idarubicin, cytarabine and cladribine (ICC).
    Wiedower, Eric
    Jamy, Omer Hassan
    Martin, Michael Gary
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] T315 Decreases Acute Myeloid Leukemia Cell Viability through a Combination of Apoptosis Induction and Autophagic Cell Death
    Chiu, Chang-Fang
    Weng, Jing-Ru
    Jadhav, Appaso
    Wu, Chia-Yung
    Sargeant, Aaron M.
    Bai, Li-Yuan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (08)
  • [8] Scoring system to predict the risk of early death during induction chemotherapy for primary acute myeloid leukemia (AML).
    Sanchez-Ortega, I.
    Valcarcel, D.
    Brunet, S.
    Esteve, Jordi
    Berlanga, J.
    Ribera, Josep-Maria
    Tormo, M.
    Bueno, J.
    Torres, P.
    Guardia, J.
    Queipo De Llano, M. P.
    Besalduch, Juan
    Llorente, A.
    Pedro, C.
    Sanchez, J. M.
    Moraleda, J. M.
    Marti, J. M.
    Bargay, J.
    Font, L. L.
    Vivancos, P.
    Hernandez, D.
    Montserrat, Emili
    Sierra, Jorge
    BLOOD, 2006, 108 (11) : 558A - 558A
  • [9] AngioCRIME in Acute Myeloid Leukemia (AML)
    Macintyre, Elizabeth
    HEMASPHERE, 2017, 1 (01):
  • [10] Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment
    Chen, Yongyu
    Qiu, Xue
    Liu, Rongrong
    BMC MEDICAL GENOMICS, 2024, 17 (01)